Market Indices
Sector Heatmap
LENZ — LENZ Therapeutics, Inc. Common Stock
NasdaqLENZ Therapeutics, Inc. Common Stock
- O
- 3.60
- H
- 3.60
- L
- 3.46
- V
- 777.36K
LENZ — Latest News & Headlines
20 StoriesShirley L. Lenz Obituary Sep 25, 2026 - Cataldo Funeral Home
Shirley L. Lenz Obituary Sep 25, 2026 Cataldo Funeral Home
LENZ Therapeutics: Below Cash For A Reason (NASDAQ:LENZ) - Seeking Alpha
LENZ Therapeutics: Below Cash For A Reason (NASDAQ:LENZ) Seeking Alpha
LENZ Dec 2027 2.500 call (LENZ271217C00002500) stock price, news, quote and history - Yahoo Finance UK
LENZ Dec 2027 2.500 call (LENZ271217C00002500) stock price, news, quote and history Yahoo Finance UK
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ PR Newswire
Gene editing stocks fall after Anthropic’s CRISPR-like discovery - TradingView
Gene editing stocks fall after Anthropic’s CRISPR-like discovery TradingView
LENZ Oct 2026 17.500 call (LENZ261016C00017500) stock price, news, quote and history - Yahoo Finance Australia
LENZ Oct 2026 17.500 call (LENZ261016C00017500) stock price, news, quote and history Yahoo Finance Australia
Gene editing stocks fall after Anthropic’s CRISPR-like discovery - Seeking Alpha
Gene editing stocks fall after Anthropic’s CRISPR-like discovery Seeking Alpha
JAGU Should I Buy - Intellectia AI
JAGU Should I Buy Intellectia AI
Lenzing's €300 Million Rights Issue Sends Shares to a 52-Week Low as Berenberg Steps Back - AD HOC NEWS
Lenzing's €300 Million Rights Issue Sends Shares to a 52-Week Low as Berenberg Steps Back AD HOC NEWS
AM Markets Need to Know: F-35 parts end up in Chinese custody, Google nears Gemini 4 launch, and more - TradingView
AM Markets Need to Know: F-35 parts end up in Chinese custody, Google nears Gemini 4 launch, and more TradingView
Lenzing's Balance Sheet Gets Its Fix: The €300 Million Question Is What Comes Next - AD HOC NEWS
Lenzing's Balance Sheet Gets Its Fix: The €300 Million Question Is What Comes Next AD HOC NEWS
Lenzing's €300 Million Cash Call: 42.5% Reference Discount Sends Shares to €13.18 - AD HOC NEWS
Lenzing's €300 Million Cash Call: 42.5% Reference Discount Sends Shares to €13.18 AD HOC NEWS
Lenzing's 10-for-9 Cash Call Kicks Off as Berenberg Cuts Target to €17 - AD HOC NEWS
Lenzing's 10-for-9 Cash Call Kicks Off as Berenberg Cuts Target to €17 AD HOC NEWS
Lenzing's €300 Million Rescue Comes With a 42.5% Discount — and a Downgrade - AD HOC NEWS
Lenzing's €300 Million Rescue Comes With a 42.5% Discount — and a Downgrade AD HOC NEWS
Lenzing's €300 Million Lifeline: Rights Issue Math, a Berenberg Downgrade, and the Fight for 14 Eu - AD HOC NEWS
Lenzing's €300 Million Lifeline: Rights Issue Math, a Berenberg Downgrade, and the Fight for 14 Eu AD HOC NEWS
Lenzing's Dual Shock: Rights Issue Arithmetic and a Berenberg Downgrade Collide - AD HOC NEWS
Lenzing's Dual Shock: Rights Issue Arithmetic and a Berenberg Downgrade Collide AD HOC NEWS
Lenzing's €300 Million Recapitalisation: A 10-for-9 Rights Issue, a Berenberg Downgrade, and the R - AD HOC NEWS
Lenzing's €300 Million Recapitalisation: A 10-for-9 Rights Issue, a Berenberg Downgrade, and the R AD HOC NEWS
Lenzing's €300 Million Rights Issue Enters Critical Week as Berenberg Downgrades - AD HOC NEWS
Lenzing's €300 Million Rights Issue Enters Critical Week as Berenberg Downgrades AD HOC NEWS
Lenzing's 42.5% Arithmetic Reset: Rights Issue Discount and a Berenberg Downgrade Land on the Same D - AD HOC NEWS
Lenzing's 42.5% Arithmetic Reset: Rights Issue Discount and a Berenberg Downgrade Land on the Same D AD HOC NEWS
Lenzing's 8.65 Euro Subscription Price Triggers Sell-Off as Rights Trading Looms - AD HOC NEWS
Lenzing's 8.65 Euro Subscription Price Triggers Sell-Off as Rights Trading Looms AD HOC NEWS